Psychoses clinical trials

Explore recruiting psychoses clinical trials.

Recruiting psychoses studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Psychoses trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Safety and efficacy of olanzapine treatment in psychosis: Effect of genetic and epigenetic factors – covariates of treatment response

Czechia

Therapeutic use (Phase IV) EU CTIS Study details

Phase III randomized, multicenter open label clinical trial to evaluate the efficacy of immunomodulatory therapy in case of psychiatric disorders with proven dysimmunity. TIM-DePisT

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A prospective, randomized, and controlled study comparing two treatment strategies (Dose REduction of Antipsychotics vs. Maintenance treatment) in patients with schizophrenia spectrum disorder after Stratification based on patients’ psychotic PHENotype: a personalized medicine approach

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimer’s Disease (ADEPT-2)

Poland, Greece, Belgium, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

Psychoses trials by city

Psychoses in Toronto Psychoses in Vancouver Psychoses in Montreal Psychoses in Calgary Psychoses in Edmonton Psychoses in Ottawa Psychoses in Winnipeg Psychoses in Quebec City Psychoses in Hamilton Psychoses in Kitchener Psychoses in London Psychoses in Halifax Psychoses in New York Psychoses in Los Angeles Psychoses in Chicago Psychoses in Houston

Psychoses clinical trials

Recruiting psychoses studies right now

Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans

Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients

Digital Navigators for Acceptance and Competence Development with Mental Health Apps

Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

Study on the Use of Exergames to Support Older Adults With Psychosis

Yoga-based Group Intervention (YoGI) for In-patients With Schizophrenia Spectrum Disorders

Norwegian Mental Illness Heart Health Study

A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418

Early Psychosis: Investigating Cognition

Evaluation of the Supported Housing System for the Inclusion of People Suffering From Mental Disorders

SPARK Healthy Sleep

Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.

Also recruiting in Europe

Safety and efficacy of olanzapine treatment in psychosis: Effect of genetic and epigenetic factors – covariates of treatment response

Phase III randomized, multicenter open label clinical trial to evaluate the efficacy of immunomodulatory therapy in case of psychiatric disorders with proven dysimmunity. TIM-DePisT

A prospective, randomized, and controlled study comparing two treatment strategies (Dose REduction of Antipsychotics vs. Maintenance treatment) in patients with schizophrenia spectrum disorder after Stratification based on patients’ psychotic PHENotype: a personalized medicine approach

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimer’s Disease (ADEPT-2)

Psychoses trials by city

Other conditions